PATOU GARY

CIK 00012835353 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001283535

Recent Transactions

50 trades

Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2025-06-05+2,645→ 2,645 total
Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2025-06-05+17,012→ 17,012 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-11-22$13.48/sh+3,086→ 26,659 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-11-22$7.38/sh+3,500→ 27,073 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-11-22$39.80/sh−1,046→ 25,613 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-11-22−3,086→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-11-22$41.11/sh−2,851→ 23,573 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-11-22$41.05/sh−2,040→ 23,573 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-11-22−3,500→ 0 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-11-22$39.80/sh−649→ 26,424 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-06-05+15,542→ 15,542 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-12-14$41.05/sh−7,598→ 4,902 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-12-13$9.85/sh+6,378→ 29,951 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-12-13$39.68/sh−1,167→ 27,550 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-12-13−2,800→ 0 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-12-13$39.68/sh−577→ 25,876 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-12-13$38.94/sh−5,100→ 23,573 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-12-13$41.05/sh−7,598→ 4,902 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-12-13$39.10/sh−2,303→ 23,573 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-12-13−5,144→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-12-13$39.84/sh−3,977→ 23,573 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-12-13$39.68/sh−1,278→ 28,673 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-12-13$9.00/sh+5,144→ 28,717 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-12-13−6,378→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-12-13$9.85/sh+2,880→ 26,453 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-06-02+18,475→ 18,475 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-11-25−2,057→ 0 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-11-25$34.37/sh−120→ 25,510 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-11-25$34.79/sh−1,937→ 23,573 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-11-25$2.68/sh+2,057→ 25,630 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-11-23$34.33/sh−2,057→ 23,573 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-06-28+18,000→ 18,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-12-08$3.67/sh+2,057→ 25,630 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-12-08−2,057→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-06-03+10,000→ 10,000 total
Small Acquisition
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-03-17$19.49/sh+100→ 100 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2020-10-28$3.76/sh+2,057→ 23,573 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-10-28−2,057→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-06-01+10,000→ 10,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-12-04$3.56/sh+2,057→ 21,516 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-12-04−2,057→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-09-16+15,000→ 15,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2018-12-14$3.07/sh+2,057→ 19,459 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-12-14−2,057→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2018-06-14$3.70/sh+8,230→ 20,258 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2018-06-14$8.30/sh−2,856→ 17,402 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-06-14−8,230→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-06-04+15,000→ 15,000 total
Purchase
Xenon Pharmaceuticals Inc.$XENE
Common Stock
2017-08-10$2.78/sh+7,500→ 12,500 total
Purchase
Xenon Pharmaceuticals Inc.$XENE
Common Stock
2017-08-08$3.00/sh+5,000→ 5,000 total

Companies

Recent Filings

Address

C/O MPM ASSET MANAGEMENT 601 GATEWAY BLVD., SUITE 350

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov